Oral Paxlovid (nirmatrelvir-ritonavir) is highly effective at preventing hospitalization and death from COVID-19, yet it has been remarkably underused, even by patients at highest risk from COVID-19, ...
Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential efficacy ...
UK COVID-19 Update: London Moves to 'High Risk' Tier 2 These are the UK coronavirus stories you need to know about today. Medscape News UK, October 15, 2020 Long COVID 'May Be Four Syndromes' Review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results